Transaction Details
- Acquirer: Sanofi Healthcare India Private Limited (promoter group entity)
- Seller: Hoechst GmbH (promoter entity)
- Target Company: Sanofi India Limited (ISIN: INE058A01010)
- Transaction Date: 24th September 2026
- Number of Shares Acquired: 3,500,000 equity shares
- Percentage of Share Capital: 15.20%
- Acquisition Price: ₹3,052 per share
- Transaction Mechanism: Block deal on stock exchange
Shareholding Changes
Pre-Transaction Holding (as of 24th September 2026):
- Sanofi Healthcare India Private Limited: Nil shares (0%)
- Hoechst GmbH: 13,904,722 shares (60.38%)
- Total Promoter & Promoter Group: 13,909,587 shares (60.40%)
Post-Transaction Holding (as of 24th September 2026):
- Sanofi Healthcare India Private Limited: 3,500,000 shares (15.20%)
- Hoechst GmbH: 10,404,722 shares (45.18%)
- Total Promoter & Promoter Group: 13,909,587 shares (60.40%)
Pricing Compliance
- The 60-day VWAP preceding the notice date (17th September 2026) was ₹3,228.06 per share
- The acquisition price of ₹3,052 per share is within 25% of the VWAP (₹3,228.06), complying with proviso (i) to Regulation 10(1)(a)
Declarations and Confirmations
- The acquirer and seller confirm they have complied with Chapter V disclosure requirements of SAST Regulations during the 3 years prior to the acquisition
- Both entities are ultimately held by the same parent entity, Sanofi France
- All conditions specified under Regulation 10(1)(a)(iii) have been duly complied with
Additional Documents
The filing includes annexures:
- Annexure A: Proof of fee payment
- Annexure B: Regulation 10(5) disclosure filed on 17th September 2026
- Annexure C: Regulation 10(6) disclosure filed on 28th September 2026
- Annexure D: Copies of Chapter V compliance disclosures from previous periods